Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity

BACKGROUND: Acute myeloid leukemia mainly affects adult patients. Complete remission for patients younger than 60 years, who are candidates for standard induction therapy, is achieved in 60%–80% of cases. However, the prognosis is still poor for older patients, who are unfit for intensive chemothera...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nanomedicine
Autori principali: Briot, Thomas, Roger, Emilie, Bou Haidar, Naila, Bejaud, Jerome, Lautram, Nolwenn, Guillet, Catherine, Thépot, Sylvain, Legeay, Samuel, Lagarce, Frederic
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440450/
https://ncbi.nlm.nih.gov/pubmed/30988610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S190482
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi